A condition that compels people to move their legs could indicate they have a greater chance of developing Parkinson's ...

FDA clears path for Phase 3 testing following positive Type B meetingRegulatory alignment confirms preclinical data sufficient for pivotal initiationPhase 3 to include two 28-day trials and a 12-month ...

B55alpha, that controls both the cleanup of damaged mitochondria and the creation of new ones. In Parkinson’s disease models, ...

But for older patients who require antipsychotic treatment, quetiapine and clozapine are considered "less risky for causing ...

The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are ...

A medication made from marijuana successfully reduced back pain in a new study WASHINGTON -- An experimental medication made from marijuana successfully reduced back pain in a new study, offering ...

The industry commits to $500 billion in investments and a new direct-purchase drug program. Steve Ubl is president and chief executive of PhRMA, a trade group representing pharmaceutical and ...

It’s becoming increasingly clear that pharmaceutical companies can live with President Trump’s tariffs. What the industry can’t live with is uncertainty on drug prices. The sector has long traded at a ...

President Donald Trump Thursday night said he would impose new tariffs on drugs, heavy trucks and furniture starting next Wednesday. Drugmakers who have broken ground on new U.S. manufacturing plants ...

Dysfunction of mitochondrial complex I (MCI) has been implicated in the degeneration of dopaminergic neurons in Parkinson’s disease. Here, we report the effect of expressing MitoLbNOX, a mitochondrial ...

PROVIDENCE, R.I. (WJAR) — Rhode Island State Police announced that a Providence man was arrested on drugs and gun charges. According to state police, they searched 5 Dresser St. and 49 Portland St. in ...

Lower the costs of development for American scientists, too. Scott Gottlieb is a senior fellow at the American Enterprise Institute and a partner at New Enterprise Associates, a venture capital firm.